Last updated: 25 Sep 2026

Your kidney function test came back with an eGFR lower than you expected. Your doctor used the words "chronic kidney disease," and your first question, understandably, is whether this can be fixed.
The honest answer is more nuanced than a simple yes or no, and it is more useful than either. True reversal, kidney function returning fully to where it was before, is uncommon once structural damage has occurred. But this is not the discouraging news it sounds like. Because the more important question is not "can it be reversed" but "can it be stopped." And the answer to that question, when caught early, is very often yes.
Patient-first, Holistic, Dedicated Healthcare
In kidney medicine, there is an important difference between two goals, and understanding it changes how you should think about a CKD diagnosis.
Reversal means kidney function returning to a healthier state, essentially undoing damage that has already occurred. This is achievable in specific, identifiable circumstances: acute kidney injury from dehydration, a medication reaction, or a temporary obstruction can often fully resolve once the cause is corrected. But once chronic, structural damage has developed, the scarred and lost nephrons (the kidney's filtering units) generally do not regenerate. The kidney does not have the same regenerative capacity as the liver.
Stabilisation means slowing or completely halting further decline, protecting the kidney function you currently have for years or decades. This is the realistic and highly achievable goal for the majority of people diagnosed with early to moderate chronic kidney disease (CKD). And critically, stabilisation is not a consolation prize. A person whose eGFR stabilises at 55 and remains there for 20 years has, in every meaningful sense, avoided the consequences of kidney disease. They will likely never need dialysis. They will likely never progress to kidney failure.
The goal shifts from reversal to stabilisation not because doctors have given up, but because stabilisation is the outcome that actually protects your health and your future.
While full reversal of established structural damage is rare, kidney function can genuinely improve, sometimes meaningfully, in several specific situations.
When the cause was reversible in the first place. Not every low eGFR reading reflects permanent damage. Dehydration, certain medications (particularly NSAIDs taken regularly), urinary obstruction, and episodes of acute illness can all temporarily reduce kidney function. When these causes are identified and corrected, eGFR can return substantially or fully to baseline. This is why your doctor may repeat a kidney function test before concluding that a low reading reflects chronic disease rather than a temporary, correctable dip.
When blood pressure and blood sugar were poorly controlled and are then optimised. Diabetes and hypertension are the two leading causes of chronic kidney disease worldwide. When either condition has been poorly controlled for a period and is then brought under good control, kidney function can genuinely stabilise, and in some documented cases, improve modestly. This is not universal, but it is well-documented in clinical literature and is one of the strongest reasons early intervention matters.
When early-stage damage is caught before significant nephron loss. CKD stages 1 and 2 (eGFR 60 and above, with some marker of kidney damage such as protein in urine) represent early, often manageable changes. At this stage, aggressive management of underlying causes offers the best chance of preventing any further decline, and function often remains stable indefinitely.
What does not typically improve. Once eGFR has declined into stage 3b (30 to 44) or beyond, the structural damage is generally established, and the realistic goal shifts firmly to stabilisation. This does not mean these stages are without hope. It means the target changes from "getting better" to "not getting worse," which remains an achievable and valuable goal.
If there is one intervention that dominates the evidence on slowing CKD progression, it is blood pressure control.
Hypertension is present in 60 to 92 per cent of people with stage 3 CKD, and it drives a vicious cycle: high blood pressure damages the small blood vessels within the kidney, and damaged kidneys struggle to regulate blood pressure, which raises it further. Breaking this cycle is one of the single most impactful things a person with CKD can do.
Despite its importance, blood pressure control in people with CKD is frequently suboptimal. The same study found that only 15 to 30 per cent of CKD patients consistently achieved guideline blood pressure targets, and as few as 13 per cent achieved the stricter 130/80 threshold recommended for higher-risk patients. This represents a significant, correctable gap between what is known to work and what is actually being achieved.
Specific classes of blood pressure medication, ACE inhibitors and ARBs, have additional kidney-protective effects beyond simply lowering blood pressure. They reduce pressure specifically within the kidney's filtering units, which slows the progression of damage independent of their effect on overall blood pressure. This is why these particular medication classes are typically the first choice for people with both hypertension and reduced kidney function.
Diabetes is the single leading cause of chronic kidney disease worldwide. Persistently elevated blood sugar damages the small blood vessels within the kidney's filtering units in much the same way it damages blood vessels in the eyes and nerves.
The relationship is dose-dependent and duration-dependent: the higher your average blood sugar and the longer it remains elevated, the greater the cumulative kidney damage. This is why HbA1c, which reflects your average blood sugar over the preceding two to three months, is such an important marker to monitor alongside kidney function in anyone with diabetes or prediabetes.
The encouraging finding is that when blood sugar is brought under good control, particularly when this happens before significant kidney damage has occurred, the trajectory of kidney function can be meaningfully altered. This is one of the strongest arguments for early and consistent diabetes management, and for regular kidney function testing in anyone with diabetes, since kidney damage can develop silently well before symptoms would ever prompt a visit to the doctor.
Beyond blood pressure and blood sugar, several additional factors have evidence for protecting kidney function.
Weight management. Excess weight independently increases the risk of both diabetes and hypertension, the two leading causes of CKD, and obesity itself has direct effects on kidney filtration pressure. Weight loss reduces this burden.
Smoking cessation. Smoking damages blood vessels throughout the body, including those within the kidneys, and accelerates the rate of kidney function decline in people who already have reduced function.
Avoiding unnecessary NSAIDs. Regular use of NSAIDs (ibuprofen, naproxen) can reduce blood flow to the kidneys and accelerate decline in people with existing reduced function. If you have CKD, discuss pain management alternatives with your doctor rather than relying on daily NSAID use.
Regular monitoring. This is deceptively simple but critical. Tracking your eGFR over time, rather than checking it once and moving on, is how you and your doctor identify whether your current management approach is working. A stable trend confirms your interventions are effective. A declining trend prompts earlier and more aggressive management before further function is lost.
The honest reframing of the question is this: the earlier CKD is detected, the more the answer resembles "yes" in practical terms, because early detection allows intervention before the damage that cannot be undone has occurred.
A person whose reduced kidney function is identified at stage 2, when eGFR is still 65 to 70, has an enormous opportunity. Aggressive management of blood pressure, blood sugar, and weight at this stage frequently prevents any meaningful further decline for the rest of that person's life. A person whose CKD is not identified until stage 4, often because no screening was done until symptoms finally appeared, has a much narrower window and a more limited set of options.
This is precisely why a Singapore health screening study finding that 3.7 per cent of screening participants had moderate to severe CKD, most of them previously undiagnosed, matters so much. Every one of those individuals identified at stage 3 rather than stage 4 has meaningfully more options for protecting their remaining kidney function.
If your recent kidney function test revealed reduced eGFR, the most productive next steps are a repeat test to confirm the finding is persistent rather than a temporary dip, assessment and optimisation of your blood pressure and blood sugar if either is elevated, a review of your current medications for any that may be affecting kidney function, and a discussion with your doctor about your specific stage, cause, and realistic goals.
At our GP clinic, early to moderate CKD is managed collaboratively, with regular monitoring, aggressive management of underlying causes, and referral to a nephrologist when the stage or complexity warrants specialist involvement. A broader health screening ensures that the conditions most likely to be driving kidney changes, diabetes, hypertension, and cholesterol, are assessed and managed together, not in isolation.
Reversal, in the strictest sense, may not be available to everyone. But protecting what you have, for years and often decades, very often is. And that protection starts with knowing your numbers early enough to act.
Patient-first, Holistic, Dedicated Healthcare
Medical Disclaimer & Limitation of Liability
The content provided in this post is strictly for informational and educational purposes. Just as we fiercely defend our right to publish general health information, we establish an uncompromising boundary: this material is never a substitute for personalised, professional medical advice, diagnosis, or treatment.
Reading this content does not establish a doctor-patient relationship. You possess the sovereign right and responsibility to manage your own health, which means you must consult your own qualified physician before making any medical decisions based on what you read here. We explicitly disclaim all medicolegal liability for any injury, loss, or risk incurred directly or indirectly from the misinterpretation, misuse, or out-of-context application of our online content. Your health is your responsibility; seek individual professional care.